Mouse Anti-ELK4 Recombinant Antibody (3D1) (V2LY-0825-LY90)

Yang, W., Gao, K., Qian, Y., Huang, Y., Xiang, Q., Chen, C., ... & Zhai, R. (2022). A novel tRNA-derived fragment AS-tDR-007333 promotes the malignancy of NSCLC via the HSPB1/MED29 and ELK4/MED29 axes. Journal of hematology & oncology, 15(1), 1-20.

Long, R., Liu, Z., Li, J., Zhang, Y., & Yu, H. (2021). HCG11 up-regulation induced by ELK4 suppressed proliferation in vestibular schwannoma by targeting miR-620/ELK4. Cancer Cell International, 21(1), 1-10.

Zheng, L., Xu, H., Di, Y., Chen, L., Liu, J., Kang, L., & Gao, L. (2021). ELK4 promotes the development of gastric cancer by inducing M2 polarization of macrophages through regulation of the KDM5A-PJA2-KSR1 axis. Journal of translational medicine, 19(1), 1-13.

Mao, X., Ji, T., Liu, A., & Weng, Y. (2021). ELK4-mediated lncRNA SNHG22 promotes gastric cancer progression through interacting with EZH2 and regulating miR-200c-3p/Notch1 axis. Cell death & disease, 12(11), 1-11.

Mao, C., Dong, W., Lu, J., Zhang, Z., Wu, H., Ghavamian, A., ... & Ding, S. (2021). βKlotho Inhibits Cell Proliferation by Downregulating ELK4 and Predicts Favorable Prognosis in Prostate Cancer. Cancer Management and Research, 13, 6377.

Zhu, Z., Song, J., Guo, Y., Huang, Z., Chen, X., Dang, X., ... & Cui, L. (2020). LAMB3 promotes tumour progression through the AKT–FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer. Oncogene, 39(24), 4666-4680.

Liu, Q., Zhu, L., Liu, X., Zheng, J., Liu, Y., Ruan, X., ... & Xue, Y. (2020). TRA2A-induced upregulation of LINC00662 regulates blood-brain barrier permeability by affecting ELK4 mRNA stability in Alzheimer’s microenvironment. RNA biology, 17(9), 1293-1308.

Olafsen, C. E., Cooper, A., Britton, J., Pira, C. U., & Oberg, K. C. (2020). An ELK4 Binding Site is Critical for Activity of the LHX2-Associated Sub-AER Regulatory Module 1 (LASARM1). The FASEB Journal, 34(S1), 1-1.

Maurice, D., Costello, P., Sargent, M., & Treisman, R. (2018). ERK signaling controls innate-like CD8+ T cell differentiation via the ELK4 (SAP-1) and ELK1 transcription factors. The Journal of Immunology, 201(6), 1681-1691.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols